LifeMD (LFMD) to Release Quarterly Earnings on Wednesday

LifeMD (NASDAQ:LFMD - Get Free Report) is scheduled to post its quarterly earnings results after the market closes on Wednesday, May 8th. Analysts expect LifeMD to post earnings of ($0.13) per share for the quarter. Individual interested in listening to the company's earnings conference call can do so using this link.

LifeMD (NASDAQ:LFMD - Get Free Report) last issued its quarterly earnings data on Monday, March 11th. The company reported ($0.12) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.14) by $0.02. The business had revenue of $44.86 million for the quarter, compared to the consensus estimate of $40.65 million. On average, analysts expect LifeMD to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

LifeMD Stock Performance

Shares of LFMD stock traded down $0.29 during mid-day trading on Wednesday, reaching $11.64. 528,744 shares of the company's stock traded hands, compared to its average volume of 808,241. The firm has a market capitalization of $469.86 million, a PE ratio of -16.63 and a beta of 1.43. The company has a debt-to-equity ratio of 3.22, a quick ratio of 1.15 and a current ratio of 1.22. The firm has a 50 day moving average price of $9.61 and a two-hundred day moving average price of $7.85. LifeMD has a 12 month low of $1.40 and a 12 month high of $12.43.

Analyst Upgrades and Downgrades

LFMD has been the subject of several recent analyst reports. BTIG Research upped their target price on shares of LifeMD from $13.00 to $14.00 and gave the stock a "buy" rating in a report on Tuesday, April 23rd. HC Wainwright upped their target price on shares of LifeMD from $10.00 to $12.00 and gave the stock a "buy" rating in a report on Thursday, January 11th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has an average rating of "Buy" and an average target price of $10.40.

LifeMD Company Profile

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.